Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/16449
Title: Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy
Austin Authors: Corbett, Mark A;Bellows, Susannah T;Li, Melody;Carroll, Renée;Micallef, Silvana ;Carvill, Gemma L;Myers, Candace T;Howell, Katherine B;Maljevic, Snezana;Lerche, Holger;Gazina, Elena V;Mefford, Heather C;Bahlo, Melanie;Berkovic, Samuel F ;Petrou, Steven;Scheffer, Ingrid E ;Gecz, Jozef
Affiliation: School of Medicine, The University of Adelaide, Adelaide, South Australia, Australia
Robinson Research Institute, The University of Adelaide, Adelaide, South Australia, Australia
School of Biological Sciences, The University of Adelaide, Adelaide, South Australia, Australia
Epilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia
Florey Institute of Neuroscience and Mental Health, Melbourne, Victoria, Australia
Division of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, WA, USA
Department of Neurology, Royal Children's Hospital, Parkville, Victoria, Australia
Neurosciences Group, Murdoch Childrens Research Institute, Melbourne, victoria, Australia
Department of Paediatrics, University of Melbourne, Royal Children's Hospital, Parkville, Victoria, Australia
Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tübingen, Germany
The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia
Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia
Department of Medicine, Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia
Issue Date: 8-Nov-2016
metadata.dc.date: 2016-10-12
Publication information: Neurology 2016; 87(19): 1975-1984
Abstract: Objective: To identify the genetic basis of a family segregating episodic ataxia, infantile seizures, and heterogeneous epilepsies and to study the phenotypic spectrum of KCNA2 mutations. Methods: A family with 7 affected individuals over 3 generations underwent detailed phenotyping. Whole genome sequencing was performed on a mildly affected grandmother and her grandson with epileptic encephalopathy (EE). Segregating variants were filtered and prioritized based on functional annotations. The effects of the mutation on channel function were analyzed in vitro by voltage clamp assay and in silico by molecular modeling. KCNA2 was sequenced in 35 probands with heterogeneous phenotypes. Results: The 7 family members had episodic ataxia (5), self-limited infantile seizures (5), evolving to genetic generalized epilepsy (4), focal seizures (2), and EE (1). They had a segregating novel mutation in the shaker type voltage-gated potassium channel KCNA2 (CCDS_827.1: c.765_773del; p.255_257del). A rare missense SCN2A (rs200884216) variant was also found in 2 affected siblings and their unaffected mother. The p.255_257del mutation caused dominant negative loss of channel function. Molecular modeling predicted repositioning of critical arginine residues in the voltage-sensing domain. KCNA2 sequencing revealed 1 de novo mutation (CCDS_827.1: c.890G>A; p.Arg297Gln) in a girl with EE, ataxia, and tremor. Conclusions: A KCNA2 mutation caused dominantly inherited episodic ataxia, mild infantile-onset seizures, and later generalized and focal epilepsies in the setting of normal intellect. This observation expands the KCNA2 phenotypic spectrum from EE often associated with chronic ataxia, reflecting the marked variation in severity observed in many ion channel disorders.
URI: http://ahro.austin.org.au/austinjspui/handle/1/16449
DOI: 10.1212/WNL.0000000000003309
ORCID: 0000-0001-5132-0774
0000-0003-4580-841X
0000-0002-2311-2174
0000-0002-7884-6861
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/27733563
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

10
checked on Dec 2, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.